Dallas – A 13-year-old Haltom City teen became the first patient at Medical City Children’s Hospital and in North Texas to benefit from a newly FDA–approved heart device that takes the open–part out of certain open-heart surgeries.

Thirteen–year old Adam Roberts was born with a complex congenital heart condition that often results in multiple open-heart surgeries throughout a lifetime. He had his first when he was just a few weeks old. This time, expert heart surgeons at Medical City Children’s Hospital were able to use a new, next generation valve technology that enables patients who otherwise would not be candidates to benefit from a minimally invasive approach.

“Each subsequent invasive surgery carries more risk than the previous one for congenital heart patients. This new, less invasive procedure not only reduces the number of open-heart surgeries but also decreases the time a patient spends in the hospital and speeds up their recovery,” says Vivian Dimas, MD, a pediatric interventional cardiologist and medical director of adult congenital heart disease at Medical City Children’s Hospital.

During the procedure, a thin catheter with a collapsed valve is inserted through a small incision in the femoral vein or neck. The valve is then transported through the vein into the right ventricular outflow tract (RVOT) of the heart. This valve is an advance in transcatheter valve technology in that it self-expands, conforming to the patient’s vessel with a custom fit and configuration, immediately directing blood flow in the proper direction. The device and minimally invasive procedure are available for pediatric and adult patients with a native or surgically repaired right ventricular outflow tract.

The Heart Center at Medical City Children's Hospital provides peace of mind by offering advanced treatment options for neonates, infants, children, adolescents and adults with all forms of congenital and acquired heart disease. Early detection of a congenital (present at birth) heart defect allows careful panning of future care.